These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26485710)

  • 1. Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
    Jonkman LE; Rosenthal DM; Sormani MP; Miles L; Herbert J; Grossman RI; Inglese M
    PLoS One; 2015; 10(10):e0129380. PubMed ID: 26485710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
    De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; Montanari E; Cifelli A; Federico A; Smith SM
    Neurology; 2003 Apr; 60(7):1157-62. PubMed ID: 12682324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
    Kuchling J; Ramien C; Bozin I; Dörr J; Harms L; Rosche B; Niendorf T; Paul F; Sinnecker T; Wuerfel J
    Mult Scler; 2014 Dec; 20(14):1866-71. PubMed ID: 24781284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment.
    Amato MP; Bartolozzi ML; Zipoli V; Portaccio E; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Neurology; 2004 Jul; 63(1):89-93. PubMed ID: 15249616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
    Damjanovic D; Valsasina P; Rocca MA; Stromillo ML; Gallo A; Enzinger C; Hulst HE; Rovira A; Muhlert N; De Stefano N; Bisecco A; Fazekas F; Arévalo MJ; Yousry TA; Filippi M
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):18-24. PubMed ID: 27686487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.
    Stellmann JP; Cetin H; Young KL; Hodecker S; Pöttgen J; Bittersohl D; Hassenstein A; Oberwahrenbrock T; Heesen C; Siemonsen S
    Brain Behav; 2017 Feb; 7(2):e00614. PubMed ID: 28239524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
    Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
    Anderson VM; Fisniku LK; Altmann DR; Thompson AJ; Miller DH
    Mult Scler; 2009 Jul; 15(7):811-7. PubMed ID: 19465449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.
    Matsushita F; Kida H; Tabei KI; Nakano C; Matsuura K; Ii Y; Sasaki R; Taniguchi A; Narita Y; Maeda M; Satoh M; Tomimoto H
    Brain Behav; 2018 Mar; 8(3):e00934. PubMed ID: 29541544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
    Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
    Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.
    Rossi S; Studer V; Moscatelli A; Motta C; Coghe G; Fenu G; Caillier S; Buttari F; Mori F; Barbieri F; Castelli M; De Chiara V; Monteleone F; Mancino R; Bernardi G; Baranzini SE; Marrosu MG; Oksenberg JR; Centonze D
    PLoS One; 2013; 8(6):e67357. PubMed ID: 23840674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
    Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
    Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.